Ecrins Therapeutics is a startup based in France, most recent round Series-c-plus, 1 tracked investor.
Ecrins Therapeutics is a company headquartered in France. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Ecrins Therapeutics is a French biotechnology company developing innovative anti-cancer drugs. Their approach targets tumor metabolism with a new mechanism of action.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.